of the Dept. of Immunotechnology won a “Best Abstract Presentation Price” at the Oral Abstract session entitled
Risk factors and biomarkers in occupational allergy
held at EAACI 2015 in Barcelona.
Andy’s contribution was entitled
Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature.
Andy Forreryd is a researcher at the Dept. of Immunotechnology at Lund University and a contributor to the R&D team connected to SenzaGen who’s research is the foundation for the GARD test products.
SenzaGen congratulates Andy and we are very proud to see that his great achievements as a researcher is getting acknowledged.